KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,007,953 | +3.7% | 104,668 | -3.1% | 0.01% | 0.0% |
| Q2 2023 | $971,775 | +23.8% | 107,975 | +8.1% | 0.01% | +25.0% |
| Q1 2023 | $784,986 | +24.3% | 99,871 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $631,472 | -54.5% | 93,413 | -2.3% | 0.00% | -55.6% |
| Q3 2022 | $1,387,000 | +114.0% | 95,586 | +45.1% | 0.01% | +125.0% |
| Q2 2022 | $648,000 | +92.3% | 65,882 | +187.8% | 0.00% | +100.0% |
| Q1 2022 | $337,000 | +59.0% | 22,893 | +42.7% | 0.00% | +100.0% |
| Q4 2021 | $212,000 | +2.4% | 16,048 | +35.0% | 0.00% | 0.0% |
| Q3 2021 | $207,000 | – | 11,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |